The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Increasing Antimicrobial Resistance and the Management of Uncomplicated Community-Acquired Urinary Tract Infections
Abstract
Community-acquired urinary tract infections (UTIs) are among the most common bacterial infections in women. Therapy for these infections is usually begun before results of microbiological tests are known. Furthermore, in women with acute uncomplicated cystitis, empirical therapy without a pretherapy urine culture is often used. The rationale for this approach is based on the highly predictable spectrum of etiologic agents causing UTI and their antimicrobial resistance patterns. However, antimicrobial resistance among uropathogens causing community-acquired UTIs, both cystitis and pyelonephritis, is increasing. Most important has been the increasing resistance to trimethoprim-sulfamethoxazole (TMP-SMX), the current drug of choice for treatment of acute uncomplicated cystitis in women. What implications do these trends have for treatment of community-acquired UTIs? Preliminary data suggest that clinical cure rates may be lower among women with uncomplicated cystitis treated with TMP-SMX when the infecting pathogen is resistant to TMP-SMX. Women with pyelonephritis also have less bacterial eradication and lower clinical cure rates when treated with TMP-SMX for an infection that is resistant to the drug. Therefore, in the outpatient setting, identifying risk factors for TMP-SMX resistance and knowing the prevalence of TMP-SMX resistance in the local community are important steps in choosing an appropriate therapeutic agent. When choosing a treatment regimen, physicians should consider such factors as in vitro susceptibility, adverse effects, cost-effectiveness, and selection of resistant strains. Using a management strategy that takes these variables into account is essential for maintaining the safety and efficacy of treatment for acute UTI.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Principles and Practice of Infectious Diseases.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-818_5 · Cited by 12,025
Warren, J. W., Abrutyn, E., Hebel, J. R., Johnson, J. R., Schaeffer, A. J., & Stamm, W. E. (1999) · Clinical Infectious Diseases · doi:10.1086/520427 · Cited by 1,188
Self-citationManagement of Urinary Tract Infections in Adults
Desforges, J. F., Stamm, W. E., & Hooton, T. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310283291808 · Cited by 899
Self-citationDIAGNOSIS AND TREATMENT OF UNCOMPLICATED URINARY TRACT INFECTION
Hooton, T. M., & Stamm, W. E. (1997) · Infectious Disease Clinics of North America · doi:10.1016/s0891-5520(05)70373-1 · Cited by 751
Self-citationGupta, K. (1999) · JAMA · doi:10.1001/jama.281.8.736 · Cited by 609
Self-citationThe Clinical Pharmacokinetics of Levofloxacin
Fish, D. N., & Chow, A. T. (1997) · Clinical Pharmacokinetics · doi:10.2165/00003088-199732020-00002 · Cited by 475
Gupta, K., Sahm, D. F., Mayfield, D., & Stamm, W. E. (2001) · Clinical Infectious Diseases · doi:10.1086/320880 · Cited by 359
Self-citationSahm, D. F., Thornsberry, C., Mayfield, D. C., Jones, M. E., & Karlowsky, J. A. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.5.1402-1406.2001 · Cited by 294
Clinical Pharmacokinetics of Ciprofloxacin
Vance-Bryan, K., Guay, D. R. P., & Rotschafer, J. C. (1990) · Clinical Pharmacokinetics · doi:10.2165/00003088-199019060-00003 · Cited by 222
Russo, T. A., Stapleton, A., Wenderoth, S., Hooton, T. M., & Stamm, W. E. (1995) · Journal of Infectious Diseases · doi:10.1093/infdis/172.2.440 · Cited by 203
Self-citation
Cited by
Uncomplicated Urinary Tract Infection
Hooton, T. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmcp1104429 · Cited by 885
Self-citationRusso, T. A., & Johnson, J. R. (2003) · Microbes and Infection · doi:10.1016/s1286-4579(03)00049-2 · Cited by 801
Setting and Revising Antibacterial Susceptibility Breakpoints
Turnidge, J., & Paterson, D. L. (2007) · Clinical Microbiology Reviews · doi:10.1128/cmr.00047-06 · Cited by 578
Johnson, J. R., Johnston, B., Clabots, C., Kuskowski, M. A., & Castanheira, M. (2010) · Clinical Infectious Diseases · doi:10.1086/653932 · Cited by 510
Stapleton, A. E., Au-Yeung, M., Hooton, T. M., Fredricks, D. N., Roberts, P. L., Czaja, C. A., Yarova-Yarovaya, Y., Fiedler, T., Cox, M., & Stamm, W. E. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/cir183 · Cited by 484
Self-citation
Metadata
- Authors
- Gupta, K., Hooton, T. M., & Stamm, W. E.
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2001-07-03
- Volume
- 135
- Issue
- 1
- Pages
- 41-50
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W2079785911
- Cited by
- 677
- References
- 23
- FWCI
- 20.68
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Increasing Antimicrobial Resistance and the Management of Uncomplicated Community-Acquired Urinary Tract Infections. https://app.cochat.ai/papers/10.7326/0003-4819-135-1-200107030-00012
- The paper
- Gupta, K., Hooton, T. M., & Stamm, W. E. (2001). Increasing Antimicrobial Resistance and the Management of Uncomplicated Community-Acquired Urinary Tract Infections. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-135-1-200107030-00012
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.